Alzchem starts production of NITRALZ® Isobutyronitrile: qualified quantities now available
At the beginning of the second quarter of 2025, Alzchem will expand its diverse portfolio of aliphatic nitriles with the first commercial production campaign of NITRALZ® Isobutyronitrile.
With this important milestone, Alzchem ensures the continuous supply of this essential raw material and positions itself as the only Western manufacturer in the global market. These guarantees supply security and flexibility for customers and are a key component of a stable, sustainable, and low-risk supply chain.
NITRALZ® Isobutyronitrile, with its high purity, functions as a critical raw material in the chemical industry, particularly in the production of pharmaceutical active ingredients and specialty chemicals. It is also the focus of current research in electrochemical processes and battery production or is already a raw material for the first commercial solutions.
In addition to delivery in tank containers, Alzchem also offers the product in drums and small qualification quantities, which will be available from now.
Act now Act together in a 100% production “made in Germany”.
Contact
Michael Schauner
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,730 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 554.2 million and EBITDA of EUR 105.3 million in 2024.